Agency Information Collection Activities; Announcement of OMB Approval; General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling Forms FDA 356h and 2567; and Revocation and Suspension

Resumen

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling Forms FDA 356h and 2567; and Revocation and Suspension" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.